The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome
Open accessAbstract
BACKGROUND: Both prophylactic and early surfactant replacement therapy reduce mortality and pulmonary complications in ventilated infants with respiratory distress syndrome (RDS) compared with later selective surfactant administration. However, continued post-surfactant intubation and ventilation are risk factors for bronchopulmonary dysplasia (BPD). The purpose of this review was to compare outcomes between two strategies of surfactant administration in infants with RDS; prophylactic or early surfactant administration followed by prompt extubation, compared with later, selective use of surfactant followed by continued mechanical ventilation. OBJECTIVES: To compare two treatment strategies in preterm infants with or at risk for RDS: early surfactant administration with brief mechanical ventilation (less than one hour) followed by extubation vs. later selective surfactant administration, continued mechanical ventilation, and extubation from low respiratory support. Two populations of infants receiving early surfactant were considered: spontaneously breathing infants with signs of RDS (who receive surfactant administration during evolution of RDS prior to requiring intubation for respiratory failure) and infants at high risk for RDS (who receive prophylactic surfactant administration within 15 minutes after birth). SEARCH STRATEGY: Searches were made of the Oxford Database of Perinatal Trials, MEDLINE (1966 - December 2006), CINAHL (1982 to December Week 2, 2006), EMBASE (1980 - December 2006), Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 4, 2006), Pediatric Research (1990 - 2006), abstracts, expert informants and hand searching. No language restrictions were applied. SELECTION CRITERIA: Randomized or quasi-randomized controlled clinical trials comparing early surfactant administration with planned brief mechanical ventilation (less than one hour) followed by extubation vs. selective surfactant administration continued mechanical ventilation, and extubation from low respiratory support. DATA COLLECTION AND ANALYSIS: Data were sought regarding effects on the incidence of mechanical ventilation (ventilation continued or initiated beyond one hour after surfactant administration), incidence of bronchopulmonary dysplasia (BPD), chronic lung disease (CLD), mortality, duration of mechanical ventilation, duration of hospitalization, duration of oxygen therapy, duration of respiratory support (including CPAP and nasal cannula), number of patients receiving surfactant, number of surfactant doses administered per patient, incidence of air leak syndromes (pulmonary interstitial emphysema, pneumothorax), patent ductus arteriosus requiring treatment, pulmonary hemorrhage, and other complications of prematurity. Stratified analysis was performed according to inspired oxygen threshold for early intubation and surfactant administration in the treatment group: inspired oxygen within lower (FiO2< 0.45) or higher (FiO2 > 0.45) range at study entry. Treatment effect was expressed as relative risk (RR) and risk difference (RD) for categorical variables, and weighted mean difference (WMD) for continuous variables. MAIN RESULTS: Six randomized controlled clinical trials met selection criteria and were included in this review. In these studies of infants with signs and symptoms of RDS, intubation and early surfactant therapy followed by extubation to nasal CPAP (NCPAP) compared with later selective surfactant administration was associated with a lower incidence of mechanical ventilation [typical RR 0.67, 95% CI 0.57, 0.79], air leak syndromes [typical RR 0.52, 95% CI 0.28, 0.96] and BPD [typical RR 0.51, 95% CI 0.26, 0.99]. A larger proportion of infants in the early surfactant group received surfactant than in the selective surfactant group [typical RR 1.62, 95% CI 1.41, 1.86]. The number of surfactant doses per patient was significantly greater among patients randomized to the early surfactant group [WMD 0.57 doses per patient, 95% CI 0.44, 0.69]. In stratified analysis by FIO2 at study entry, a lower threshold for treatment (FIO2< 0.45) resulted in lower incidence of airleak [typical RR 0.46 and 95% CI 0.23, 0.93] and BPD [typical RR 0.43, 95% CI 0.20, 0.92]. A higher treatment threshold (FIO2 > 0.45) at study entry was associated with a higher incidence of patent ductus arteriosus requiring treatment [typical RR 2.15, 95% CI 1.09, 4.13]. AUTHORS' CONCLUSIONS: Early surfactant replacement therapy with extubation to NCPAP compared with later selective surfactant replacement and continued mechanical ventilation with extubation from low ventilator support is associated with less need mechanical ventilation, lower incidence of BPD and fewer air leak syndromes. A lower treatment threshold (FIO2< 0.45) confers greater advantage in reducing the incidences of airleak syndromes and BPD; moreover a higher treatment threshold (FIO2 at study > 0.45) was associated with increased risk of PDA. These data
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Northway, W. H., Rosan, R. C., & Porter, D. Y. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760701 · Cited by 3,013
Treatment of the Idiopathic Respiratory-Distress Syndrome with Continuous Positive Airway Pressure
Gregory, G. A., Kitterman, J. A., Phibbs, R. H., Tooley, W. H., & Hamilton, W. K. (1971) · New England Journal of Medicine · doi:10.1056/nejm197106172842401 · Cited by 1,259
Is Chronic Lung Disease in Low Birth Weight Infants Preventable? A Survey of Eight Centers
Avery, M. E., Tooley, W. H., Keller, J. B., Hurd, S. S., Bryan, M. H., Cotton, R. B., Epstein, M. F., Fitzhardinge, P. M., Hansen, C. B., Hansen, T. N., et al. (1987) · Pediatrics · doi:10.1542/peds.79.1.26 · Cited by 875
Rojas-Reyes, M. X., Morley, C. J., & Soll, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000510.pub2 · Cited by 652
Self-citationEarly versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
Bahadue, F. L., & Soll, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001456.pub2 · Cited by 556
Self-citationVerder, H., Robertson, B., Greisen, G., Ebbesen, F., Albertsen, P., Lundstrom, K., & Jacobsen, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311603 · Cited by 448
Synchronized mechanical ventilation for respiratory support in newborn infants
Greenough, A., Rossor, T. E., Sundaresan, A., Murthy, V., & Milner, A. D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000456.pub5 · Cited by 255
Soll, R., & Özek, E. (1997) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000511 · Cited by 226
Self-citationPulmonary disease following respiratory therapy of hyaline-membrane disease
Hendren, W. H. (1967) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(67)90014-0 · Cited by 226
Continuous distending pressure for respiratory distress in preterm infants
Ho, J. J., Subramaniam, P., Henderson-Smart, D. J., & Davis, P. G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002271 · Cited by 197
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
Moore, T., Hennessy, E. M., Myles, J., Johnson, S. J., Draper, E. S., Costeloe, K. L., & Marlow, N. (2012) · BMJ · doi:10.1136/bmj.e7961 · Cited by 779
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Rojas-Reyes, M. X., Morley, C. J., & Soll, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000510.pub2 · Cited by 652
Self-citationEarly versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
Bahadue, F. L., & Soll, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001456.pub2 · Cited by 556
Self-citationSweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Plavka, R., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., et al. (2013) · Neonatology · doi:10.1159/000349928 · Cited by 550
Göpel, W., Kribs, A., Ziegler, A., Laux, R., Hoehn, T., Wieg, C., Siegel, J., Avenarius, S., von der Wense, A., Vochem, M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60986-0 · Cited by 466
Surfactant Replacement Therapy for Preterm and Term Neonates With Respiratory Distress
Polin, R. A., Carlo, W. A., COMMITTEE ON FETUS AND NEWBORN, Papile, L.-A., Polin, R. A., Carlo, W., Tan, R., Kumar, P., Benitz, W., Eichenwald, E., et al. (2014) · Pediatrics · doi:10.1542/peds.2013-3443 · Cited by 413
Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries
Adam, T., Lim, S. S., Mehta, S., Bhutta, Z. A., Fogstad, H., Mathai, M., Zupan, J., & Darmstadt, G. L. (2005) · BMJ · doi:10.1136/bmj.331.7525.1107 · Cited by 365
Randomized Trial Comparing 3 Approaches to the Initial Respiratory Management of Preterm Neonates
Martin, R. J. (2012) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/j.ynpm.2012.05.007 · Cited by 352
Respiratory Support in Preterm Infants at Birth
COMMITTEE ON FETUS AND NEWBORN, Papile, L.-A., Baley, J. E., Benitz, W., Cummings, J., Eichenwald, E., Kumar, P., Tan, R. C., & Wang, K. S. (2014) · Pediatrics · doi:10.1542/peds.2013-3442 · Cited by 330
Subramaniam, P., Ho, J. J., & Davis, P. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001243.pub3 · Cited by 318
Isayama, T., Iwami, H., McDonald, S., & Beyene, J. (2016) · JAMA · doi:10.1001/jama.2016.10708 · Cited by 310
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Engle, W. A., & and the Committee on Fetus and Newborn (2008) · Pediatrics · doi:10.1542/peds.2007-3283 · Cited by 308
Nanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Plavka, R., Saugstad, O. D., Simeoni, U., Speer, C. P., & Halliday, H. L. (2010) · Neonatology · doi:10.1159/000297773 · Cited by 287
Lung Ultrasound in Respiratory Distress Syndrome: A Useful Tool for Early Diagnosis
Copetti, R., Cattarossi, L., Macagno, F., Violino, M., & Furlan, R. (2008) · Neonatology · doi:10.1159/000113059 · Cited by 287
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Principi, N., Di Pietro, G. M., & Esposito, S. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1417-7 · Cited by 267
Animal derived surfactant extract for treatment of respiratory distress syndrome
Seger, N., & Soll, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007836 · Cited by 260
Self-citationEfficacy and safety of CPAP in low-and middle-income countries
Thukral, A., Sankar, M. J., Chandrasekaran, A., Agarwal, R., & Paul, V. K. (2016) · Journal of Perinatology · doi:10.1038/jp.2016.29 · Cited by 114
Davey, M.-A., Watson, L., Rayner, J. A., & Rowlands, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004902.pub5 · Cited by 53
Metadata
- Authors
- Stevens, T. P., Blennow, M., Myers, E. H., & Soll, R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-10-17
- Volume
- 2008
- Issue
- 3
- Pages
- CD003063-CD003063
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2044324900
- Cited by
- 597
- References
- 14
- FWCI
- 33.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.